TraceLink customers receive EMVO approval for data submission to EU Hub

6 Jun 2018

Company has developed a standard feature for its customers to execute the EMVO conformance testing successfully.

TraceLink has developed a streamlined program for its 190+ customers to rapidly complete conformance testing and successfully receive European Medicines Verification Organization (EMVO) approval to submit data to the EU Hub - a complex and lengthy process that requires each company to complete EMVO registration and provide a full set of test cases to be executed for conformance with the EU Hub.

TraceLink customers receive EMVO approval for data submission to EU Hub

In just one month, 34 companies have completed their conformance testing with TraceLink’s conformance test kit. Of these, 11 companies have received EMVO approval to submit data to the EU Hub and 14 companies are awaiting review from the EMVO. To achieve final approval, all pharmaceutical companies must now submit a series of transactions to be reviewed by the EMVO, a process that can now take several weeks due to the surge of companies seeking to connect to the EU Hub before the EU Falsified Medicines Directive (FMD) deadline in February 2019. Once the transactions are approved by the EMVO, a pharmaceutical company will receive access to the certificates required for production and data submission to the EU Hub.

To accommodate the more than 190 customers that have selected TraceLink to help meet their EU Falsified Medicines Directive (FMD) requirements, TraceLink has developed a standard feature for its customers to execute the EMVO conformance testing successfully, including specific product functionality and services optimized to help guide customers through the EMVO approval process for connection to the EU Hub. After executing a conformance test, any TraceLink customer using the EU compliance module will receive automatically generated files that are ready to be submitted to the EU Hub for approval.

“The EMVO has stated that there is no longer a formal certification for pharmaceutical companies or solution providers to gain access to the EU Hub, so pharmaceutical companies that are still evaluating solutions should be skeptical of any vendor statements claiming they are ‘EMVO certified.’ The true test is demonstrating how many pharmaceutical companies have actually achieved EMVO approval using a particular solution provider, as this validates correct use of the EU Hub integration APIs,” said Shabbir Dahod, president and CEO of TraceLink. “TraceLink’s history integrating with the EU Hub dates back 2 years, with nearly 650,000 serial numbers submitted to the EU Hub by our customers since 2016. Today, while other solution providers are in the midst of conducting pilot tests and resorting to promotional discount strategies in an attempt to acquire new customers, TraceLink customers are out front, already live in production with serialization and officially approved to submit data to the EU Hub.”

“After working with TraceLink to successfully complete our conformance testing, we have received EMVO approval to begin submitting data to the EU Hub, nearly 10 months ahead of the EU FMD deadline,” said Ortwin Kottwitz, CEO of biosyn. “Gaining EMVO certification with the TraceLink conformance test kit was simple and straightforward, and with TraceLink’s multi-tenant approach, we are well-positioned for continued certification despite any unforeseen changes to our systems in the future.”

Read More

Related news

Zenith Technologies sees 400% China growth in latest Asia success

Zenith Technologies sees 400% China growth in latest Asia success

22 May 2019

Company plans to double its operations in the country over the next 3 years and expand its work with local companies as well as continuing to support global multinationals.

Read more 
Online training for pharmaceutical and nutraceutical professionals

Online training for pharmaceutical and nutraceutical professionals

21 May 2019

Modules include a variety of subjects from an ’Introduction to tablet tooling’ and ‘Tooling maintenance’, to ‘Troubleshooting production problems’ and ‘Improving productivity’.

Read more 
FDA approves TraceLink DSCSA pilot submission for network solutions

FDA approves TraceLink DSCSA pilot submission for network solutions

20 May 2019

Delivering 2023 traceability by leveraging blockchain and digital recalls across a supply network.

Read more 
UK and US customers set to benefit from Wasdell Group acquisition

UK and US customers set to benefit from Wasdell Group acquisition

17 May 2019

Increased manufacturing and packaging capacity and service in the UK allows company to better service growing client base in the US who require a fully outsourced supply chain for their products within Europe.

Read more 
Improving gut health with human milk oligosaccharides

Improving gut health with human milk oligosaccharides

17 May 2019

2’-FL a very promising agent for digestive health across various age groups beyond infancy.

Read more 
Expert forecasts huge growth in Middle East manufacturing

Expert forecasts huge growth in Middle East manufacturing

16 May 2019

UAE consumers and insurance companies are willing to pay for highest quality drug products.

Read more 
Colorcon's breakthrough for direct compression

Colorcon's breakthrough for direct compression

15 May 2019

New starch-based excipient plays an important role in enhancing the stability of moisture-sensitive APIs.

Read more 
Legacy plans for lyophilisation boom

Legacy plans for lyophilisation boom

14 May 2019

The increase in biologics is driving the growth in demand for lyophilization in vials.

Read more 
Lessons learned from early EU FMD adopters

Lessons learned from early EU FMD adopters

13 May 2019

Data exchange, investment costs, resources and hardware identified as some of the biggest challenges.

Read more 
Catalent achieves global ISO accreditation

Catalent achieves global ISO accreditation

12 May 2019

Company is one of the first CDMOs to receive award.

Read more